All Research
    PAPER CERT2-Meta-analysis2022

    CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis

    Meta-analysis in patients with established coronary artery disease: the CERT2 ceramide-phospholipid score stratified major adverse cardiovascular event risk and added prognostic value beyond conventional lipids.

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    Journal of Clinical Lipidology

    Mar 2022

    03

    Structured Methods

    Study Design
    Meta-analysis
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2022). CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis. Journal of Clinical Lipidology.

    Source

    Publisher

    Journal

    Journal of Clinical Lipidology

    05

    Indexing

    Biomarkers

    ceramides
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation